These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 15280546)

  • 1. Prospects for total synthesis: a vision for a totally synthetic vaccine targeting epithelial tumors.
    Keding SJ; Danishefsky SJ
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):11937-42. PubMed ID: 15280546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the power of chemical synthesis: immunological evaluation of models for multiantigenic carbohydrate-based cancer vaccines.
    Ragupathi G; Coltart DM; Williams LJ; Koide F; Kagan E; Allen J; Harris C; Glunz PW; Livingston PO; Danishefsky SJ
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13699-704. PubMed ID: 12359877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: clinical trial results with alpha-N-acetylgalactosamine-O-serine/threonine conjugate vaccine.
    Slovin SF; Ragupathi G; Musselli C; Olkiewicz K; Verbel D; Kuduk SD; Schwarz JB; Sames D; Danishefsky S; Livingston PO; Scher HI
    J Clin Oncol; 2003 Dec; 21(23):4292-8. PubMed ID: 14645418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From synthesis to biologics: preclinical data on a chemistry derived anticancer vaccine.
    Zhu J; Wan Q; Lee D; Yang G; Spassova MK; Ouerfelli O; Ragupathi G; Damani P; Livingston PO; Danishefsky SJ
    J Am Chem Soc; 2009 Jul; 131(26):9298-303. PubMed ID: 19518111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbohydrate vaccines in cancer: immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man.
    Slovin SF; Ragupathi G; Adluri S; Ungers G; Terry K; Kim S; Spassova M; Bornmann WG; Fazzari M; Dantis L; Olkiewicz K; Lloyd KO; Livingston PO; Danishefsky SJ; Scher HI
    Proc Natl Acad Sci U S A; 1999 May; 96(10):5710-5. PubMed ID: 10318949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer.
    Slovin SF; Ragupathi G; Musselli C; Fernandez C; Diani M; Verbel D; Danishefsky S; Livingston P; Scher HI
    Cancer Immunol Immunother; 2005 Jul; 54(7):694-702. PubMed ID: 15726361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constructing an adenocarcinoma vaccine: immunization of mice with synthetic KH-1 nonasaccharide stimulates anti-KH-1 and anti-Le(y) antibodies.
    Ragupathi G; Deshpande PP; Coltart DM; Kim HM; Williams LJ; Danishefsky SJ; Livingston PO
    Int J Cancer; 2002 May; 99(2):207-12. PubMed ID: 11979435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pursuit of optimal carbohydrate-based anticancer vaccines: preparation of a multiantigenic unimolecular glycopeptide containing the Tn, MBr1, and Lewis(y) antigens.
    Allen JR; Harris CR; Danishefsky SJ
    J Am Chem Soc; 2001 Mar; 123(9):1890-7. PubMed ID: 11456809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel and efficient method for synthetic carbohydrate conjugate vaccine preparation: synthesis of sialyl Tn-KLH conjugate using a 4-(4-N-maleimidomethyl) cyclohexane-1-carboxyl hydrazide (MMCCH) linker arm.
    Ragupathi G; Koganty RR; Qiu D; Lloyd KO; Livingston PO
    Glycoconj J; 1998 Mar; 15(3):217-21. PubMed ID: 9579798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A preclinical study comparing approaches for augmenting the immunogenicity of a heptavalent KLH-conjugate vaccine against epithelial cancers.
    Ragupathi G; Koide F; Sathyan N; Kagan E; Spassova M; Bornmann W; Gregor P; Reis CA; Clausen H; Danishefsky SJ; Livingston PO
    Cancer Immunol Immunother; 2003 Oct; 52(10):608-16. PubMed ID: 12811527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyclonal antibodies from patients immunized with a globo H-keyhole limpet hemocyanin vaccine: isolation, quantification, and characterization of immune responses by using totally synthetic immobilized tumor antigens.
    Wang ZG; Williams LJ; Zhang XF; Zatorski A; Kudryashov V; Ragupathi G; Spassova M; Bornmann W; Slovin SF; Scher HI; Livingston PO; Lloyd KO; Danishefsky SJ
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2719-24. PubMed ID: 10716997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic carbohydrate-based antitumor vaccines: challenges and opportunities.
    Ouerfelli O; Warren JD; Wilson RM; Danishefsky SJ
    Expert Rev Vaccines; 2005 Oct; 4(5):677-85. PubMed ID: 16221069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keyhole limpet hemocyanin conjugate vaccines against cancer: the Memorial Sloan Kettering experience.
    Musselli C; Livingston PO; Ragupathi G
    J Cancer Res Clin Oncol; 2001 Oct; 127 Suppl 2():R20-6. PubMed ID: 11768620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of antigen constructs and carrier molecules for augmenting the immunogenicity of the monosaccharide epithelial cancer antigen Tn.
    Kagan E; Ragupathi G; Yi SS; Reis CA; Gildersleeve J; Kahne D; Clausen H; Danishefsky SJ; Livingston PO
    Cancer Immunol Immunother; 2005 May; 54(5):424-30. PubMed ID: 15625606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a mouse monoclonal IgG3 antibody to the tumor-associated globo H structure produced by immunization with a synthetic glycoconjugate.
    Kudryashov V; Ragupathi G; Kim IJ; Breimer ME; Danishefsky SJ; Livingston PO; Lloyd KO
    Glycoconj J; 1998 Mar; 15(3):243-9. PubMed ID: 9579801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccines prepared with sialyl-Tn and sialyl-Tn trimers using the 4-(4-maleimidomethyl)cyclohexane-1-carboxyl hydrazide linker group result in optimal antibody titers against ovine submaxillary mucin and sialyl-Tn-positive tumor cells.
    Ragupathi G; Howard L; Cappello S; Koganty RR; Qiu D; Longenecker BM; Reddish MA; Lloyd KO; Livingston PO
    Cancer Immunol Immunother; 1999 Apr; 48(1):1-8. PubMed ID: 10235483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and evaluation of unimolecular pentavalent and hexavalent antigenic constructs targeting prostate and breast cancer: a synthetic route to anticancer vaccine candidates.
    Ragupathi G; Koide F; Livingston PO; Cho YS; Endo A; Wan Q; Spassova MK; Keding SJ; Allen J; Ouerfelli O; Wilson RM; Danishefsky SJ
    J Am Chem Soc; 2006 Mar; 128(8):2715-25. PubMed ID: 16492059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of multifunctional gold nanoparticles bearing tumor-associated glycopeptide antigens as potential cancer vaccines.
    BrinĂ£s RP; Sundgren A; Sahoo P; Morey S; Rittenhouse-Olson K; Wilding GE; Deng W; Barchi JJ
    Bioconjug Chem; 2012 Aug; 23(8):1513-23. PubMed ID: 22812418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbohydrate vaccines as immunotherapy for cancer.
    Slovin SF; Keding SJ; Ragupathi G
    Immunol Cell Biol; 2005 Aug; 83(4):418-28. PubMed ID: 16033538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy for cancer: synthetic carbohydrate-based vaccines.
    Buskas T; Thompson P; Boons GJ
    Chem Commun (Camb); 2009 Sep; (36):5335-49. PubMed ID: 19724783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.